R106L (p.Arg106Leu) variant of TNXB (Tenascin-X)

R106L (p.Arg106Leu) in TNXB (Tenascin-X) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Cardiovascular phenotype. The available variant effect predictions contribute to a CATVariant prioritization score of 0.70 / 1. The record also includes population frequency data and structural context.

R106L (p.Arg106Leu) variant details